Archit Pharma Innovations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -8.11%
- Profit Growth -21.91%
- Ebitda -18.70%
- Net Worth 74.72%
- Total Assets 83.70%
About Archit Pharma Innovations
Archit Pharma Innovations Private Limited (APIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 August 2011 and has a history of 13 years and five months. Its registered office is in Chhatarpur, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Urmila and Archana Pahariya serve as directors at the Company.
Company Details
-
Location
Chhatarpur, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP2011PTC026552
-
Company No.
026552
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Aug 2011
-
Date of AGM
14 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
What products or services does Archit Pharma Innovations Private Limited offer?
Archit Pharma Innovations Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Surface Cleaner, Soaps, Detergent Powder & Cakes, Dishwashing Detergents.
Who are the key members and board of directors at Archit Pharma Innovations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urmila
|
Director | 17-Jun-2021 | Current |
|
Archana Pahariya
|
Director | 04-Feb-2019 | Current |
Financial Performance of Archit Pharma Innovations.
Archit Pharma Innovations Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.11% decrease. The company also saw a substantial fall in profitability, with a 21.91% decrease in profit. The company's net worth Soared by an impressive increase of 74.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Archit Pharma Innovations?
In 2020, Archit Pharma Innovations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Archit Pharma Innovations?
Unlock and access historical data on people associated with Archit Pharma Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Archit Pharma Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Archit Pharma Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
